l-CDL, a natural compound, was found to attenuate TCI-induced chronic bone cancer pain by antagonizing spinal D1DR and D2DR to inhibit D1/D2DR heteromers, and in turn downstream CaMKII and MAPKs signaling. The gene discussed is DRD2; the disease is bone neoplasm.